「Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib」の関連論文
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
-
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
-
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
-
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
-
Comparison of efficacy and safety outcomes of anticancer drugs between Japanese patients and the overall population in multi-regional clinical trials
-
Clinical impact of detecting low-frequency variants in cell-free DNA on treatment of castration-resistant prostate cancer
-
Combination of RERG and ZNF671 methylation rates in circulating cell-free DNA: A novel biomarker for screening of nasopharyngeal carcinoma
-
Real-world application of next-generation sequencing-based test for surgically resectable colorectal cancer in clinical practice (本文)
-
Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
-
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma (本文)
-
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
-
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
-
Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas : significance of cell adhesion and epithelial–mesenchymal transition-related signaling pathways (本文)
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
-
Clinical and Basic Research for Ovarian Cancer
-
A genome-wide association study identifying single nucleotide polymorphisms in the PPFIBP2 gene was predictive for interstitial lung disease in rheumatoid arthritis patients
-
Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing (本文)
-
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
-
miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma
-
Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese : the Japan Multi-Institutional Collaborative Cohort Study
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma
-
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
-
Functional and genomic characterization of patient-derived xenograft model to study adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma
-
Clinical Significance of Serum Antithrombin III Activity After Hepatectomy for Hepatocellular Carcinoma
-
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
-
Malignant Progression of Diffuse Low-grade Gliomas : A Systematic Review and Meta-analysis on Incidence and Related Factors.
-
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
-
Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma
-
A novel urinary microRNA biomarker panel for detecting gastric cancer
-
Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma
-
分子標的薬時代における転移性腎癌の腫瘍縮小率が予後に与える影響
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
光力学診断補助下経尿道的膀胱腫瘍切除術(PDD-TURBT)の初期経験
-
Plasma cytokine levels and the presence of colorectal cancer
-
A large-scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy